Compare Revvity Inc (RVTY) vs Stitch Fix Inc (SFIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revvity Inc vs Stitch Fix Inc — how do they compare? Revvity Inc trades at $116.31 (market cap $12.91B), while Stitch Fix Inc trades at $3.57 (market cap $497.68M). The key difference: Revvity Inc is far larger — about 25.9× Stitch Fix Inc's market cap, and Revvity Inc pays a 0.24% dividend while Stitch Fix Inc pays none. Which is the better fit depends on your goals.
| RVTY | SFIX | |
|---|---|---|
Market Cap | $12.91B | $497.68M |
Sector | Technology | Consumer Cyclical |
52-Week High | $117.75 | $5.83 |
52-Week Low | $82.26 | $3.06 |
Enterprise Value | $15.23B | $385.40M |
Dividend Yield | 0.24% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RVTY trades at $115.18, down 0.72% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported strong Q2 2026 earnings of $1.41 per share, beating estimates, and raised its full-year outlook, driven by diagnostics strength and AI-enabled drug discovery. Revenue for 2025 was $2.86 billion with a net income margin of 8.16%, though valuation ratios like P/E of 55.64 appear elevated. Recent news includes product launches like the SuperFlex prenatal system and presentations at investor conferences.
The outlook is positive with analyst consensus favoring a buy rating and a $120.50 price target, suggesting upside. Key opportunities include robust diagnostics demand and innovation pipelines, while risks involve high valuation multiples and competitive pressures in the healthcare sector. Cash flow improved in 2026 to a net positive $31 million, supporting growth initiatives.
Stitch Fix (SFIX) trades at $3.565, down 10.2% in the past day, reflecting recent volatility. The stock shows a bullish technical signal with improving earnings trends, as recent quarters beat EPS estimates. Revenue stabilized at $1.27B in 2025, with net losses narrowing to -$28.74M, indicating progress toward profitability. News highlights AI-driven personalization efforts and new executive appointments aimed at growth.
The outlook suggests a turnaround opportunity, supported by a low P/S ratio of 0.37 and a consensus price target of $4.75 (33% upside). Risks include persistent net losses, competitive pressures, and consumer spending sensitivity. Analysts are mixed, with 27% buy ratings, but improving cash flow and debt-free balance sheet provide stability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →About Stitch Fix Inc
Stitch Fix Inc offers personal style service for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandises with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types and price points including Women's, Petite, Maternity, Men's and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry and handbags, and sells merchandise across various range of price points.
Read more on SFIX →
